Try Fund Library Premium

Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports
  • Portfolio Rebalancer new

Pharmala Biotech Holdings Inc. (MDMA : CSE)

Sector: Healthcare

Close
(11-04-2026)
$0.16
Change
-$0.03 (-15.79%)
Volume 360,211
Open $0.17
Day Range $0.15 - $0.18
52 Week Low $0.09
52 Week High $0.33
Annual Yield -
Annual Dividend -
Last Dividend -
Industry Sector Healthcare
Quoted Market Value $17,474,765
Shares Outstanding 109,217,282
Book Value per Share $9.50
Earnings per Share -$0.01
Period
Loading......
Loading......

Legend

Pharmala Biotech Holdings Inc.

Compare Options


Pricing History (Last 30 Days)

Pricing History
Date Close Change
November 04, 2026 0.16
-$0.03 (-15.79%)
November 03, 2026 0.19
$0.01 (2.70%)
November 02, 2026 0.19
$0.02 (8.82%)
October 30, 2026 0.17
$0.01 (6.25%)
October 29, 2026 0.16
$0.00 (0.00%)
October 28, 2026 0.16
-$0.01 (-3.03%)
October 27, 2026 0.17
$0.00 (0.00%)
October 26, 2026 0.17
$0.01 (3.13%)
October 23, 2026 0.16
-$0.01 (-3.03%)
October 22, 2026 0.17
-$0.02 (-8.33%)
October 21, 2026 0.18
$0.01 (2.86%)
October 20, 2026 0.18
$0.02 (9.38%)
October 19, 2026 0.16
$0.01 (3.23%)
October 16, 2026 0.16
-$0.03 (-13.89%)
October 15, 2026 0.18
-$0.02 (-10.00%)
October 14, 2026 0.20
$0.00 (0.00%)
October 13, 2026 0.20
-$0.02 (-6.98%)
October 12, 2026 0.22
$0.00 (0.00%)
October 09, 2026 0.22
$0.01 (2.38%)
October 08, 2026 0.21
-$0.02 (-6.67%)
October 07, 2026 0.23
-$0.02 (-8.16%)
October 06, 2026 0.25
$0.00 (0.00%)
October 05, 2026 0.25
$0.00 (0.00%)
October 02, 2026 0.25
$0.02 (6.52%)
October 01, 2026 0.23
$0.01 (2.22%)
September 30, 2026 0.23
$0.01 (2.27%)
September 29, 2026 0.22
-$0.01 (-2.22%)
September 28, 2026 0.23
-$0.01 (-2.17%)
September 25, 2026 0.23
-$0.02 (-6.12%)
September 24, 2026 0.25
$0.00 (0.00%)

Funds holding this stock

Try Fund Library Premium

Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports
  • Portfolio Rebalancer new